Pseudolaric acid B-O-β-D-glucopyranoside
Analytical reference substance, >98%
- Product Code: 54106
CAS:
98891-41-9
| Molecular Weight: | 594.60422 g./mol | Molecular Formula: | C₂₉H₃₈O₁₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 766.5±60.0℃ at 760 mmHg | |
| Density: | 1.42 g/cm3 | Storage Condition: | room temperature |
Product Description:
Pseudolaric acid B-O-β-D-glucopyranoside is primarily studied for its potential therapeutic applications, particularly in the field of oncology. Research indicates that it exhibits significant anti-cancer properties, making it a candidate for the development of novel cancer treatments. It has been shown to inhibit the proliferation of various cancer cell lines, including those associated with breast, lung, and liver cancers. The compound works by inducing apoptosis, or programmed cell death, in malignant cells, thereby reducing tumor growth. Additionally, it has been observed to enhance the efficacy of conventional chemotherapy drugs, suggesting a role in combination therapies. Beyond oncology, there is emerging interest in its anti-inflammatory and immunomodulatory effects, which could be harnessed for treating autoimmune diseases and chronic inflammatory conditions. Its ability to modulate key signaling pathways involved in cell survival and inflammation further underscores its potential as a multi-target therapeutic agent. Ongoing studies aim to explore its safety profile, pharmacokinetics, and potential for clinical application.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.020 | 10-20 days | ฿15,192.00 |
+
-
|
Pseudolaric acid B-O-β-D-glucopyranoside
Pseudolaric acid B-O-β-D-glucopyranoside is primarily studied for its potential therapeutic applications, particularly in the field of oncology. Research indicates that it exhibits significant anti-cancer properties, making it a candidate for the development of novel cancer treatments. It has been shown to inhibit the proliferation of various cancer cell lines, including those associated with breast, lung, and liver cancers. The compound works by inducing apoptosis, or programmed cell death, in malignant cells, thereby reducing tumor growth. Additionally, it has been observed to enhance the efficacy of conventional chemotherapy drugs, suggesting a role in combination therapies. Beyond oncology, there is emerging interest in its anti-inflammatory and immunomodulatory effects, which could be harnessed for treating autoimmune diseases and chronic inflammatory conditions. Its ability to modulate key signaling pathways involved in cell survival and inflammation further underscores its potential as a multi-target therapeutic agent. Ongoing studies aim to explore its safety profile, pharmacokinetics, and potential for clinical application.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :